Virtual Library
Start Your Search
L. Lisha
Author of
-
+
P2.01 - Advanced NSCLC (ID 618)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
- Presentations: 1
- Moderators:
- Coordinates: 10/17/2017, 09:00 - 16:00, Exhibit Hall (Hall B + C)
-
+
P2.01-059 - Breast Metastasis from Pulmonary Cancer: A Case Report. University Hospital "Shefqet Ndroqi" Tirana Albania 2008 (ID 7953)
09:00 - 09:00 | Author(s): L. Lisha
- Abstract
Background:
Breast metastasis from the lung malignancy is very rare. An incidence of 0.1% to 1.6 % . The most commonly of primary malignant disease that metastasize to the breast are lymphoid tissue malignancy ,malignant hemopoetic disease, and malignant melanoma.
Method:
In our experience we have had only one case with breast cancer metastazis from primary lung cancer. A 56-year-old female ex smoker ,manifested a right breast mass and limphonods in the right axillar region.She was treated for primary lung cancer stage IIB befor 4 months.Although she was treated for right spontaneous pneumothorax six years ago through right posterolateral thoracotomy ,wedge bulectomy superior dexter ,fruotazh and pleural drainage.After 3 years she was treated and for metastasectomy left lung and lateral chest wall resection coste 6/7.
Result:
The patient underwent right local mastectomy and right axillary dissection . After histological and immunohistochemical analyses showed that breast mass was metastasis from a primary lung carcinoma
Conclusion:
A accuracy treatment and prognosis of the breast metastasis from primary lung cancer is differentiation from the primary brest cancer and is very important to do this diferentation.
-
+
P3.16 - Surgery (ID 732)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Surgery
- Presentations: 1
- Moderators:
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.16-005 - Outcome, Mortality and Morbidity after Lung Cancer Thoracic Surgery (ID 7899)
09:30 - 09:30 | Author(s): L. Lisha
- Abstract
Background:
Introduction:Lung cancer is the most common form and cause of cancer death world-wide. Radical surgical resection, with or without adjuvant treatment, is still a prerequisite for cure.In European countries the proportion of patients who undergo surgery for this disease varies between 10 and 30% .Advances in operative and postoperative care have led to a decline in complications and mortality rates during the last two decades.In spite of different additional modes of treatment, survival is still poor.
Method:
The study comprised 388 consecutive patients referred to University Hospital of Lung Disease Tirane, from a defined population, during a 12-years period (2004-2017).There were in total 968 patients who underwent lung resection for bronchogenic carcinoma.There were 690 males and 278 females included 15-87 years with a mean age of 65.5 years.Postoperative events studied were divided into major and minor complications or death during the first 30 days after surgery.
Result:
Early mortality (within 30 days) after lung cancer surgery.During the study period an increasing number of women and of patients older than 70 years underwent surgery.The 30 day mortality rate was 3.4% (33 patients), 1.2% after single lobectomy(11 patients) and 3.1 % after pneumonectomy(22 patients).Major complications occurred in 48 patients (4.9%). Minor complications occurred in 75 patients (7.7%).Male gender, smoker, FEV1 70% of expected value, squamous cell carcinoma and pneumonectomy were risk factors predicting adverse outcome .
Conclusion:
Our results show low mortality and morbidity after lung cancer surgery.However, patients with reduced lung capacity and those undergoing pneumonectomy should be treated with great care, as they run a considerable risk of major complications or death during the first 30 days postoperatively.Older age (>70 years) does not appear to be a contraindication to lung cancer surgery, but patients in this group should undergo careful preoperative evaluation.
